| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 02/10/2005 | WO2004039469A3 Process of purifying phosphoramidites |
| 02/10/2005 | US20050033044 Methods for preparing 2-alkynyladenosine derivatives |
| 02/10/2005 | US20050033043 Process for preparing purine nucleosides |
| 02/10/2005 | US20050032738 (E)-2'-deoxy-2'-fluoromethylidenecytidine, cytidine, vinblastine, or fluorouracil; leukemia |
| 02/10/2005 | US20050032723 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/10/2005 | US20050032717 Avermectin b1 derivatives having an aminosulfonyloxy substituent in the 4"- position |
| 02/10/2005 | US20050031588 2'-branched nucleosides and Flaviviridae mutation |
| 02/10/2005 | CA2514466A1 Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections |
| 02/09/2005 | EP1504049A1 Monomers containing polyoxyalkylenes and polymer supports therefrom |
| 02/09/2005 | CN1578784A Preparation and isolation of indolocarbazole glycosides |
| 02/09/2005 | CN1576371A Pyrimidine nucleosides preparation method and novel pyrimidine nucleoside |
| 02/08/2005 | US6852866 For use as enzyme inhibitors and chemical intermediates; combinatorial libraries |
| 02/08/2005 | US6852746 6-((2,2- diphenylethyl)amino)-9-(N-ethyl- beta -D-ribofuranosyluronamide)-N--(2-(N'-(1-(2-pyridyl)-4 -piperidyl)ureido)ethyl)-9H-purine-2-carboxamide |
| 02/08/2005 | US6852715 Formula (1) wherein R1 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon atoms; and R2 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon |
| 02/08/2005 | US6852535 A transcribed non-naturally occurring RNA molecule comprising a desired RNA molecule, wherein the 3' region of the RNA is able to base-pair with at least 8 bases at the 5' terminus of the same RNA molecule |
| 02/03/2005 | WO2005009418A2 Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c |
| 02/03/2005 | WO2005009287A2 Drug delivery to the inner ear and methods of using same |
| 02/03/2005 | US20050027130 Rhodamine dye compounds for patterns with DNA sequences for kits |
| 02/03/2005 | US20050026936 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 02/03/2005 | US20050026864 Bisphosphonate conjugates and methods of making and using the same |
| 02/03/2005 | US20050026853 Anti-viral 7-deaza D-nucleosides and uses thereof |
| 02/03/2005 | US20050025815 Protonated/acidified nucleic acids are effective as bactericidal and/or bacteriostatic agents |
| 02/03/2005 | CA2533384A1 Indolopyrrolocarbazole derivative and antitumor agent |
| 02/03/2005 | CA2533375A1 Crystalline 6-n-pyridylmethylaminoindolocarbazole compounds |
| 02/03/2005 | CA2533367A1 Purine nucleoside analogues for treating flaviviridae including hepatitis c |
| 02/02/2005 | EP1501851A1 Process for preparing oligonucleotides |
| 02/02/2005 | EP1501850A2 Nucleoside derivatives for treating hepatitis c virus infection |
| 02/02/2005 | EP1501849A1 4"-deoxy-4"-(s)-amido avermectin derivatives |
| 02/02/2005 | EP1501848A1 Synthesis of locked nucleic acid derivatives |
| 02/02/2005 | EP1256588B1 Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both |
| 02/02/2005 | EP1011688B1 Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases |
| 02/02/2005 | CN1575181A Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 02/02/2005 | CN1575180A Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives |
| 02/02/2005 | CN1187363C Covalently linked oligonucleotide minor groove binder conjugates |
| 02/01/2005 | US6849726 Non-nucleotide containing RNA |
| 02/01/2005 | US6849270 Releasable linkage and compositions containing same |
| 01/27/2005 | US20050020827 Thermolabile hydroxyl protecting groups and methods of use |
| 01/27/2005 | US20050020826 Mixing a pyrimidine derivative having a specific base sequence with a sample suspected of containing a target nucleic acid having a base sequence that is complementary or complementary to the compound's base sequence to form a complex, |
| 01/27/2005 | US20050020825 Reacting a D-fructose with CaO to obtain a 2-C-methyl-D-ribonic- gamma -lactone; reducing, coupling with unprotected base such as cytosine in presence of silylating agent |
| 01/27/2005 | US20050020532 Partial and full agonists of A1 adenosine receptors |
| 01/26/2005 | EP1152009B1 Novel nucleosides and oligonucleotide analogues |
| 01/26/2005 | EP0975373B1 Radionuclide associated with nucleotide polyphosphate as tumor imaging agents |
| 01/26/2005 | CN1571793A Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571792A Process for the preparation of 2'-halo-beta-l-arabinofuranosyl nucleosides |
| 01/26/2005 | CN1569870A Nucleotide analogs with six-membered rings |
| 01/26/2005 | CN1186349C Process for producing adenosine by chemical synthesis |
| 01/25/2005 | US6846918 Purine nucleosides or nucleotides modified at 2-, 6- or 8-position of purine ring, prepared by reacting purine starting material containing leaving group attached to 2-, 6-or 8-position of starting material with functionalized alkene |
| 01/25/2005 | US6846810 Antiviral nucleoside derivatives |
| 01/20/2005 | WO2005005450A1 Method of synthesizing cyclic bisdinucleoside |
| 01/20/2005 | US20050014801 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 01/20/2005 | US20050014716 Pancreatic cancer treatment |
| 01/20/2005 | US20050014715 Inosine compounds and their use for treating or preventing an inflammation or reperfusion disease |
| 01/19/2005 | EP1497455A2 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
| 01/19/2005 | EP1497303A2 Reagents for monitoring nuclei acid amplification and methods of using same |
| 01/19/2005 | EP1496911A1 Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases |
| 01/19/2005 | EP1409497B1 Method for preparation of lna phosphoramidites |
| 01/19/2005 | EP1027365B1 Antitumour uridine analogues |
| 01/19/2005 | CN1566130A Nucleoside analogue lipid derivative and salt thereof |
| 01/19/2005 | CN1185247C Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 01/19/2005 | CN1185244C Rebescensine A derivatives and preparing process thereof |
| 01/18/2005 | US6844433 Nucleic acid labeling compounds |
| 01/18/2005 | US6844183 Antibiotic for use in the treatment and prevention of infections |
| 01/18/2005 | US6844173 Strain of Streptomyces griseus |
| 01/13/2005 | WO2005003374A2 SYNTHESIS OF β-L-2-DEOXY NUCLEOSIDES |
| 01/13/2005 | WO2005003295A2 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 01/13/2005 | WO2005003291A2 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 01/13/2005 | WO2005003147A2 Modified fluorinated nucleoside analogues |
| 01/13/2005 | WO2004096197A3 5-aza-7-deazapurine nucleosides for treating flaviviridae |
| 01/13/2005 | WO2003086408A8 Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases |
| 01/13/2005 | US20050009778 Method for treating retinal degeneration with purinergic receptor agonists |
| 01/13/2005 | US20050009777 Non-natural carbon-linked nucleotides and dinucleotides |
| 01/13/2005 | US20050009775 Hepatitis c virus; viricides |
| 01/13/2005 | US20050009737 Modified fluorinated nucleoside analogues |
| 01/13/2005 | US20050009058 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 01/13/2005 | US20050009054 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsDNA |
| 01/13/2005 | US20050009043 Prodrugs of phosphonate nucleotide analogues |
| 01/13/2005 | US20050009014 Sequence specific reagents attached to a solid substrate and capable of specifically binding to predetermined subunit sequence (polynucleotide or polypeptide) |
| 01/13/2005 | CA2749227A1 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 01/13/2005 | CA2734066A1 Modified fluorinated nucleoside analogues |
| 01/13/2005 | CA2734055A1 Modified fluorinated nucleoside analogues |
| 01/13/2005 | CA2734052A1 Modified fluorinated nucleoside analogues |
| 01/13/2005 | CA2733842A1 Modified fluorinated nucleoside analogues |
| 01/13/2005 | CA2563362A1 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 01/13/2005 | CA2531412A1 Synthesis of .beta.-l-2'-deoxy nucleosides |
| 01/13/2005 | CA2502610A1 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 01/12/2005 | EP1495040A1 Method for synthesizing beta-l-fluoro-2',3'didehydcytidine (beta-l-fd4c) |
| 01/12/2005 | EP1494685A1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside |
| 01/12/2005 | EP1453602A4 Compositions and methods for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences |
| 01/12/2005 | CN1563030A Method for preparing 2', 3'2-dideoxycytidine |
| 01/12/2005 | CN1184228C Process for the preparation of a deoxyuridine derivative |
| 01/12/2005 | CN1184227C Prodn. method of avermectin compounds |
| 01/11/2005 | US6841566 Viral polymerase inhibitors |
| 01/06/2005 | WO2005000864A1 Processes for preparing 4’azido nucleoside derivatives |
| 01/06/2005 | WO2005000204A2 Pancreatic cancer treatment |
| 01/06/2005 | WO2004096138A3 [18f]-furanosylpurine derivatives and uses thereof |
| 01/06/2005 | US20050004357 Industrially scalable nucleoside synthesis |
| 01/06/2005 | US20050004356 Linker nucleoside, its preparation and use |
| 01/06/2005 | US20050004148 Human immunodeficiency and hepatitis B infections; high activity, low toxicity |
| 01/06/2005 | US20050004078 Nucleotide analogs with six-membered rings |
| 01/06/2005 | US20050004053 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |